Veralox Therapeutics
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.
Veralox Therapeutics is active in the biotechnology, medical, pharmaceutical, therapeutics space based in Washington DC Metro Area, East Coast, Southern US, founded in 2017.
As a business in biotechnology, medical, pharmaceutical, therapeutics, Veralox Therapeutics is listed here with the public details available about it.
Its base of operations is Washington DC Metro Area, East Coast, Southern US.
Directory data places it at the Series_Unknown stage.
The company reports a headcount in the c_00001_00010 range.
It has disclosed roughly $47.5M in funding.
| Sector | Biotechnology, Medical, Pharmaceutical, Therapeutics |
|---|---|
| Headquarters | Washington DC Metro Area, East Coast, Southern US |
| Founded | 2017 |
| Employees | c_00001_00010 |
| Stage | series_unknown |
| Total funding | $47,460,000 |
Website: www.veralox.com
Browse related
Sign in to view the contact information we hold for Veralox Therapeutics.
Create a free account
Create a free account